Shouxi Xu

发表

Histamine receptor‐subtype affinities, selectivities, and potencies of emedastine, a novel H1‐selective antagonist, and other ocularly employed antihistamines

N. Sharif, J. Yanni, Shouxi Xu, 1994 .

Human Non-Pigmented Ciliary Epithelium Bradykinin B2-Receptors: Receptor Localization, Pharmacological Characterization of Intracellular Ca2+ Mobilization, and Prostaglandin Secretion

N. Sharif, Linya Li, C. Kelly, 2014, Current eye research.

Human conjunctival epithelial cell responses to platelet-activating factor (PAF): signal transduction and release of proinflammatory cytokines

N. Sharif, J. Yanni, I. Pang, 2009, Molecular vision.

Trabecular meshwork bradykinin receptors: mRNA levels, immunohistochemical visualization, signaling processes pharmacology, and linkage to IOP reduction.

N. Sharif, Linya Li, S. Yacoub, 2014, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Enhanced room temperature NO2 sensing performance based on N-doped carbon nanosheets@ZnO nanoplates by morphology transition and white light illumination

Yafei Zhang, Wanfei Li, Jing Hu, 2022, Applied Surface Science.

Protein expression, biochemical pharmacology of signal transduction, and relation to intraocular pressure modulation by bradykinin B2 receptors in ciliary muscle

N. Sharif, S. Cao, Linya Li, 2013, Molecular vision.

Molecular pharmacology of the DP/EP2 class prostaglandin AL-6598 and quantitative autoradiographic visualization of DP and EP2 receptor sites in human eyes.

Gary W. Williams, J. Crider, N. Sharif, 2004, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Preclinical pharmacology of AL-12182, a new ocular hypotensive 11-oxa prostaglandin analog.

J. Crider, N. Sharif, M. Mclaughlin, 2006, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Rapid Identification of Novel Inhibitors of the Human Aquaporin‐1 Water Channel

N. Sharif, A. Mitra, M. Wax, 2016, Chemical biology & drug design.

FR‐190997, a Nonpeptide Bradykinin B2‐Receptor Partial Agonist, is a Potent and Efficacious Intraocular Pressure Lowering Agent in Ocular Hypertensive Cynomolgus Monkeys

N. Sharif, Linya Li, C. Crosson, 2014, Drug development research (Print).

Preclinical pharmacology, ocular tolerability and ocular hypotensive efficacy of a novel non-peptide bradykinin mimetic small molecule.

N. Sharif, C. Belmonte, Byron Li, 2014, Experimental eye research.

Designing one-dimensional hierarchical Cu@Cu2O/CuO core-shell heterostructure for highly sensitive detection of NO2 at room temperature

Yafei Zhang, Wanfei Li, Jing Hu, 2023, Sensors and Actuators B: Chemical.

Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.

J. Crider, S. Xu, N. Sharif, 2003, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Olopatadine (AL-4943A): ligand binding and functional studies on a novel, long acting H1-selective histamine antagonist and anti-allergic agent for use in allergic conjunctivitis.

S. Xu, N. Sharif, J. Yanni, 1996, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.